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Introduction. Reconstruction by proximal gastrojejunostomy, and distal biliary and pancreatic anastomoses is infrequently used
after resection of the head of the pancreas because of fear of ﬁstulas and cholangitis. Pancreaticoduodenectomy is being performed
more frequently for cystic malignant and premalignant lesions. Because of this there is a need for endoscopic visualization and
biopsyoftheresidualpancreaticduct,sincemulti-centricityischaracteristicofsomeofthesemalignancies.Sinceendoscopicaccess
of the bile duct and pancreatic duct is diﬃcult and unsuccessful in 50–70% after B II or Roux Y reconstruction, we prospectively
studied the merit and complications (early and late) of proximal gastrojejunal (PGJ) reconstruction after pancreaticoduodenal
resection. Material and Methods. Thirty nine consecutive, non-radomized patients underwent pancreaticoduodenectomy and PGJ
reconstructionover14mos.Therewere21malesand18females.Results.7patientswithIPMNhaveundergonerepeatCTscanning
forsurveillance,with3requiringrepeatEUSandERCP.Therewerenotechnicaldiﬃcultiesaccessingthepancreasorthepancreatic
duct, supporting the PGJ reconstruction. Conclusion. Proximal gastrojejunal reconstruction following pancreaticoduodenal
resection may be safely done with similar morbidity to traditional pancreaticojejunal reconstructions. PGJ reconstruction may
be of greater value when direct visual access to the bile duct or pancreatic duct is necessary, and should be considered when doing
resection for mucinous cysts or IPMN of the head of the pancreas.
1.Introduction
Alimentary reconstruction during pancreaticoduodenal
resection invariably places the gastric or duodenal jejunal
anastomoses distal to the biliary and pancreatic anastomoses
[1, 2]. Despite absence of supporting literature this is
done for alleged fears of pancreatic and biliary ﬁstulas that
will delay oral feedings and prolong hospitalization. With
more PDRs being done for premalignant and malignant
pancreatic cystic and ductal lesions, surveillance of the
remnant pancreatic duct mucosa for multicentricity may
be necessary [3]. We undertook this study to determine the
value and risk of proximal B1 gastrojejunal reconstruction.
There has been an increase in cystic malignant and
premalignant lesions being treated by pancreaticoduodenal
resection. Because of this there is a need for endoscopic
visualization and biopsy of the residual pancreatic duct for
future surveillance because multicentricity is characteristic
of some of these malignancies. Endoscopic access of the
bile duct and pancreatic duct is diﬃcult and unsuccessful
in up to 50–70% of cases after Billroth II (B2) or Roux-en-
Y reconstruction. We prospectively studied the merit and
complications of proximal gastrojejunal (PGJ) reconstruc-
tion after pancreaticoduodenal resection. We believe this
facilitates endoscopic access to the pancreas and pancreatic
duct, which is necessary during surveillance.
2.MaterialandMethods
Thirty-nine consecutive, nonrandomized patients under-
went pancreaticoduodenectomy and PGJ reconstruction
over 14 months. There were 21 males and 18 females. The
mean age was 61.8 ± 12.6y e a r s .P r e o p e r a t i v eC Ts c a n s ,
ERCP, and endoscopic ultrasound (EUS) were performed
to establish resectability. The indications for surgery were:2 International Journal of Surgical Oncology
carcinoma of the pancreas in 26 patients ﬁve of whom
(12.5%) were initially unresectable and downstaged with
neoadjuvant chemotherapy. Seven other patients had main
duct intraductal papillary mucinous neoplasms (IPMN); 2
had ampullary cancers, one a gastrointestinal stromal tumor
(GIST) tumor involving the pancreas and duodenum, and
3 had distal common bile duct cancers. After standard pan-
creaticoduodenal resection the jejunal limb is measured and
the anastomoses are performed. The biliary anastomosis is
performedﬁrstinaduct-to-mucosafashion.Thisisfollowed
by the pancreatic anastomosis, which is constructed in a
duct-to-mucosa fashion and a second layer suturing serosa
of jejunum to capsule of pancreas. The ﬁnal anastomosis
is the gastrojejunal, which was made with a GIA stapling
device, after ﬁrst resecting a portion of the stomach. All the
anastomoses are retrocolic. Postoperatively, on endoscopic
examination,theorderisgastric,pancreatic,andthenbiliary,
all accessible via a single eﬀerent limb from the stomach.
The anastomoses are approximately 10cm apart from each
other.
3. Results
There was no operative peri-operative mortality. The mean
o p e r a t i v et i m ew a s1 7 8m i n± 21min, and estimated blood
loss 262cc ± 116cc. There were no intraoperative transfu-
sions given. The postoperative morbidity was (48%) and was
ofsurgicalsigniﬁcancein3patients(7%).Thethreeincluded
a visceral artery pseudoaneurysm in 1 patient (2.5%),
an embolic event to an intestinal branch of the superior
mesenteric artery in 1 patient (2.5%) and a gastrojejunal
leak in 1 patient (2.5%). The latter two complications
required reoperation. Other complications included a type
A pancreatic ﬁstula in 2 patients (5%), delayed gastric
emptying in 1 patient (2.5%), pneumonia in 3 patients
(7.5%), superﬁcial wound infection in 4 patients (10%),
atelectasis in 3 patients (7.5%) and Clostridium diﬃcile
colitis in 2 patients (5%). Readmission after discharge was
necessary in 1 patient. One patient with adenocarcinoma of
the head of the pancreas developed recurrence with biliary
andgastricobstruction11monthsaftersurgeryandrequired
a reoperation. One patient required endoscopic dilatation of
a symptomatic pancreaticojejunal anastomotic stricture 10
months after surgery.
All 7 patients with IPMN have undergone repeat CT
scanning for surveillance, with 3 requiring repeat EUS
and ERCP. There were no technical diﬃculties accessing
the pancreas or the pancreatic duct, supporting the PGJ
reconstruction.
4. Discussion
Despite a century of surgery for periampullary cancer,
survival remains dismal despite signiﬁcant reduction in
operative mortality and major morbidity [4, 5]. Operative
preferences and techniques for PDR are many and for the
most part do not impact on long-term survival [2]T h e
ultimate determinant of outcome is systemic metastases
present long before tumor discovery [2, 6]. Reconstruc-
tion after resection is invariably done by proximal biliary
and pancreatic enteric anastomoses and distal gastric or
duodenal enteric anastomoses. Proximal placement of the
gastro or duodenal jejunal anastomosis is neither advocated
nor reported because of unsubstantiated concern that a
pancreatic or bile leak distal to the stomach or duodenum
would cause sepsis or cholangitis, delay oral feeding, and
prolong hospitalization. This has been a long-standing, oral,
preceptor-based surgical tradition. An extensive literature
search of published case reports and case series as well
as retrospective and prospective studies over the past 10
years did not result in any citations referencing proximal
placement of the gastroenteric anastomosis during PDR.
There has been little reason or need to question this since
ERCPafterPDRforpancreaticcancerisinfrequentlyneeded.
Pancreatic ﬁstulas are not uncommon after PDR and range
from6%to25%,mostofwhichclosespontaneously,without
sepsis or therapy (type A) [7]. The two pancreatic ﬁstulas
in this series closed spontaneously and the B1 arrangement
did not delay or further complicate this. A small, unreported
previous personal experience with pyloric preservation and
proximal duodenal jejunal anastomoses was stopped because
of delayed gastric emptying. The proximal placement of the
duodenojejunostomy in that experience was noncontribu-
tory. With the increase in pancreatic incidental lesions found
bybodyimaging,anumberofpancreaticresectionsarebeing
done for intraductal papillary mucinous neoplasm (IPMN),
a lesion that creates concerns because of its multicentricity
and clinical recurrence after segmental pancreatic resection
[8, 9].
The 3 surgical complications in this report warrant com-
ment. One, an embolic episode occurred after dissecting
the superior mesenteric artery, necessitating a small bowel
resection, and resulting in a complicated and lengthy course.
This was unrelated to the gastric reconstruction. A direct
complication, a gastric leak from a stapled corner of the
transected stomach, prolonged hospitalization and required
operative closure. This is infrequent in our experience and
is independent of the type of gastric anastomosis. Local
recurrence of pancreatic cancer causing obstruction of the
biliary or gastric anastomoses and requiring surgery is
not frequent. At least 30% of PDR done for pancreatic
cancer will recur locally in the bed of resection [2, 10].
When intervention is needed for biliary obstruction, the
percutaneous approach is preferred. In this instance, 1 of 26
patients(4%)thatunderwentB1gastrojejunostomyrequired
surgery after attempts at endoscopic therapy failed to stent
the obstruction.
In 4/7 IPMN patients, postoperative surveillance raised a
concern about the remnant pancreatic duct. In each instance
ERCPcannulationwassuccessfulandtheductwasvisualized
directly in three patients. Endoscopic cannulation of the
biliary and pancreatic duct after a Roux en Y reconstruction
or a B2 with an aﬀerent limb of varying length is more
diﬃcult and unsuccessful in >50% of attempts (kinking,
angulations, and scarring of the aﬀerent limb mar success
[11, 12]). Success rates as low as 8% have been reported post
Whipple ERCP and the diﬃculties complications are wellInternational Journal of Surgical Oncology 3
stated in a website summarizing the diﬃculties of ERCP with
nativeandalteredPDandBDanatomyafterB2resection[13,
14]. Chahal et al. noted a success rate of 51% in 45/88 ERCP
attempts after pancreaticoduodenectomy. Success was much
morelikelyforbiliaryindications,37/44patients(84%),than
for pancreatic indications, 3/37 patients (8%) [13].
In view of the fact that local recurrence after resection for
cancer of the pancreas is at least 30% and there is a chance
that this can cause gastric outlet obstruction that may be
diﬃcult to treat endoscopically we will use B1 reconstruction
selectively, particularly for main duct IPMN.
5. Conclusion
Proximal gastrojejunal reconstruction following pancreati-
coduodenal resection may be safely done with similar mor-
bidity to traditional pancreaticojejunal reconstructions. PGJ
reconstruction may be of greater value when direct visual
access to the bile duct or pancreatic duct is necessary, and
should be considered when doing resection for mucinous
cysts or IPMN of the head of the pancreas. Concerns about
pancreatic ﬁstula delaying feeding were not evident in this
study. Previous experience with this reconstruction and type
A or B pancreatic ﬁstula has shown this to be a theoretical
concern. To date it has been a value in 4 of 7 patients.
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